Streetbeat News

Revenues

UUU

Universal Security Instruments reported a Q1 EPS of $(0.19), a decline from $0.07 in the previous year. Sales also decreased to $4.59M from $6.69M last year.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 8:32 pm

SPGI

S&P Global (NYSE:SPGI) has significantly outperformed the market over the past decade, with an annualized return of 19.96%. A $1000 investment in SPGI 10 years ago would now be worth $6,213.84. This highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 8:30 pm

BURL

Burlington Stores (NYSE:BURL) has significantly outperformed the market over the past decade, with an average annual return of 22.23%. A $100 investment in BURL 10 years ago would now be worth $740.55. This highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 8:30 pm

PIK

KIDPIK reported a Q2 EPS of $(0.67), an improvement from $(1.31) last year, but experienced a significant revenue decrease of 67.3% to $1.1 million.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 8:27 pm

AKTX

Akari Therapeutics appoints Samir R. Patel as interim CEO and plans to prioritize Peak Bio's ADC cancer therapeutic platform and Akari's PAS-nomacopan for geographic atrophy. The company secured $7.6 million in financing and received positive FDA feedback.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 8:26 pm

FN

Fabrinet has announced its Q1 adjusted EPS guidance of $2.33-$2.40, surpassing the estimated $2.26. The company also projects revenue between $760M-$780M, exceeding the expected $749.24M.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 8:24 pm

SIDU

Sidus Space (NASDAQ:SIDU) reported a significant improvement in its Q2 EPS, reducing losses from $(6.85) to $(0.99) per share year-over-year. However, sales decreased by 32.29% to $927.57K from $1.37M.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 8:23 pm

COCP

Cocrystal Pharma, Inc. (NASDAQ:COCP) will present at two investment conferences, highlighting near-term clinical milestones. They plan to report results from their influenza A and norovirus/coronavirus studies in 2024 and 2025.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 8:11 pm

AREN

The Arena Group Holdings reported a Q2 EPS of $(0.28), an improvement from $(0.88) year-over-year, while revenue decreased to $27.183 million from $34.072 million.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 8:08 pm

AGAE

Allied Gaming (NASDAQ:AGAE) reported a significant decline in its Q2 financial performance, with EPS dropping to $(0.09) from $(0.02) YoY and sales decreasing by 19.22% to $2.64M.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 8:08 pm